GKOS vs. PEN: Glaukos vs. Penumbra Stock Comparison
How do Glaukos (GKOS) and Penumbra (PEN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Glaukos (GKOS) and Penumbra (PEN) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | GKOS | PEN |
|---|---|---|
| Name | Glaukos Corp. | Penumbra Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 13.28 billion USD | 12.58 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 25, 2015 | September 18, 2015 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GKOS | PEN |
|---|---|---|
| Total Return (1Y) | 179.91% | 20.52% |
| Total Return (3Y, Annualized) | 55.51% | 20.38% |
| Total Return (5Y, Annualized) | 35.14% | 3.15% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GKOS | PEN |
|---|---|---|
| Volatility (1Y, Annualized) | 61.24% | 19.78% |
| Beta (5Y) | 0.68 | 0.68 |
| Max Drawdown (5Y) | -53.68% | -59.60% |
| Avg. Volume (3M) | 1.15M | 348.64K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GKOS | PEN |
|---|---|---|
| Sharpe Ratio (1Y) | 2.87 | 0.82 |
| Sortino Ratio (1Y) | 5.93 | 1.56 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Penumbra (PEN) reports 10.67%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
PEN
Health Care Equipment & Services industry group
10.67%
- Max
- 47.61%
- Q3
- 14.36%
- PEN
- 10.67%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile Penumbra (PEN) reports 10.06%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
PEN
Health Care Equipment & Services industry group
10.06%
- Max
- 29.35%
- PEN
- 10.06%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Glaukos (GKOS) at 0.39% and Penumbra (PEN) at 12.37% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
PEN
Health Care Equipment & Services industry group
12.37%
- Max
- 35.43%
- Q3
- 14.14%
- PEN
- 12.37%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GKOS | PEN |
|---|---|---|
| ROE (TTM) | -22.84% | 10.67% |
| ROA (TTM) | -3.90% | 6.28% |
| Net Margin (TTM) | -24.60% | 10.06% |
| Operating Margin (TTM) | 0.39% | 12.37% |
| Gross Margin (TTM) | 81.13% | 67.99% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while Penumbra (PEN) at 17.50% is closer to the peer norm — faster top-line expansion for GKOS.
EPS Growth
Only one side can be read here: Penumbra (PEN) reports EPS growth of 1,155.56%, ranked against its industry; Glaukos (GKOS) has no EPS growth figure this period.
Growth Metrics
| Metric | GKOS | PEN |
|---|---|---|
| Revenue Growth (YoY) | 32.33% | 17.50% |
| Revenue Growth (3Y CAGR) | 21.51% | 18.33% |
| EPS Growth (YoY) | -- | 1,155.56% |
| EPS Growth (3Y CAGR) | -- | -- |
Financial Strength
Current Ratio (MRQ)
Both Glaukos (GKOS) at 4.57 and Penumbra (PEN) at 5.89 post current ratio above their industries’ typical mid-ranges — short-term liquidity appears comfortable, though unusually high readings can point to idle current assets.
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
PEN
Health Care Equipment & Services industry group
5.89
- Max
- 7.59
- PEN
- 5.89
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Glaukos (GKOS) at 0.15 and Penumbra (PEN) at 0.13 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
PEN
Health Care Equipment & Services industry group
0.13
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- PEN
- 0.13
- Min
- 0.00
Financial Strength Metrics
| Metric | GKOS | PEN |
|---|---|---|
| Current Ratio (MRQ) | 4.57 | 5.89 |
| Debt / Equity (MRQ) | 0.15 | 0.13 |
| Net Debt / EBITDA | -- | -2.22 |
Dividends
Dividend Yield (TTM)
Neither Glaukos (GKOS) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PEN
Health Care Equipment & Services industry group
0.00%
- PEN
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Glaukos (GKOS) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PEN
Health Care Equipment & Services industry group
0.00%
- PEN
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GKOS | PEN |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Penumbra (PEN) trades at 80.41 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
PEN
Health Care Equipment & Services industry group
80.41
- PEN
- 80.41
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both look expensive on sales: Penumbra (PEN) at 8.06 sits in the upper P/S ratio quartile, and Glaukos (GKOS) at 19.24 prices even higher, above its industry range.
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PEN
Health Care Equipment & Services industry group
8.06
- Max
- 8.80
- PEN
- 8.06
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Both look rich against book: Penumbra (PEN) at 7.95 sits in the upper P/B ratio quartile, and Glaukos (GKOS) at 18.51 prices even higher, above its industry range.
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
PEN
Health Care Equipment & Services industry group
7.95
- Max
- 11.68
- PEN
- 7.95
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GKOS | PEN |
|---|---|---|
| P/E Ratio (TTM) | -- | 80.41 |
| P/S Ratio (TTM) | 19.24 | 8.06 |
| P/B Ratio (MRQ) | 18.51 | 7.95 |
| Free Cash Flow Yield (TTM) | 0.40% | 1.32% |